Intellectual Property India Publishes Patent Application for 'Methods Of Making Fusion Polypeptides' Filed by Ankyra Therapeutics, Inc.

MUMBAI, India, June 20 -- Intellectual Property India has published a patent application (202527051138 A) filed by Ankyra Therapeutics, Inc., Cambridge, U.S.A., on May 28, for 'methods of making fusion polypeptides.'

Inventor(s) include Schmidt, Michael; and Zarbis-Papastoitsis, Grigorios.

The application for the patent was published on June 20, under issue no. 25/2025.

According to the abstract released by the Intellectual Property India: "The present disclosure provides surprisingly useful fusion polypeptides including an immunomodulatory moiety and a metal-hydroxide binding moiety, as well as various related technologies, including methods of making and of using such fusion polypeptides."

The patent application was internationally filed on Nov. 08, 2023, under International application No.PCT/US2023/036996.

Disclaimer: Curated by HT Syndication.